SCHEMBL6931786

SCHEMBL6931786

C=CC(=O)[C]=Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 1/20 0.43
ALDH1A1 P00352 3/20 0.41
TSHR P16473 1/20 0.41
TGM2 P21980 1/20 0.39
LMNA P02545 3/20 0.39
MAPT P10636 3/20 0.39
CYP1A2 P05177 2/20 0.39
HDAC3 O15379 2/20 0.39
HDAC4 P56524 2/20 0.39
HDAC1 Q13547 2/20 0.39
HDAC2 Q92769 2/20 0.39
HDAC8 Q9BY41 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
PLIN1 O60240 2/20 0.39
RECQL P46063 2/20 0.39
PLIN5 Q00G26 2/20 0.39
ABHD5 Q8WTS1 2/20 0.39
TNKS O95271 1/20 0.39
HCAR2 Q8TDS4 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1322885 1.00 AKT1 (0.43) AKT1ALDH1A1TSHRTGM2LMNA
SCHEMBL7858222 0.78 LMNA (0.44) ALDH1A1LMNAMAPTCYP1A2HDAC3
SCHEMBL11377387 0.78 LMNA (0.44) ALDH1A1LMNAMAPTCYP1A2HDAC3
SCHEMBL9360731 0.78 LMNA (0.44) ALDH1A1LMNAMAPTCYP1A2HDAC3
Acrylic Acid SCHEMBL6716395 0.75 HDAC3 (0.43) AKT1ALDH1A1TSHRTGM2LMNA
SCHEMBL9509384 0.74 AKR1C3 (0.48) ALDH1A1TSHRLMNAMAPTCYP1A2
SCHEMBL9509381 0.74 AKR1C3 (0.48) ALDH1A1TSHRLMNAMAPTCYP1A2
SCHEMBL6249968 0.69 KMT2A (0.42) ALDH1A1TSHRHDAC3HDAC4HDAC1
SCHEMBL6249973 0.69 KMT2A (0.42) ALDH1A1TSHRHDAC3HDAC4HDAC1
SCHEMBL1304893 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1365805-A2 NOVEL TARGETED COMPOSITIONS FOR DIAGNOSTIC AND THERAPEUTIC USE Imarx Therapeutics, Inc. (US) 2003-12-03 EP disclosed
WO-2002036161-A2 NOVEL TARGETED COMPOSITIONS FOR DIAGNOSTIC AND THERAPEUTIC USE IMARX THERAPEUTICS, INC. (US) 2002-05-10 WO disclosed